Rx/Reimbursement Adult Incontinence in Serbia

  • Product Code:
    RP-ID-10327936
  • Published Date:
    31 Jul 2020
  • Region:
    Global
  • Pages:
    19
  • Category:
    Healthcare & Pharmaceuticals
  • Publisher:
    Pub-ID-36

Impact Analysis on the Growth of Market

Activating Probable Propositions Amidst COVID-19 Crisis

With things going haywire, we analyze key points to make sure that the businesses around the globe are completely prepared to tackle potential implications caused by COVID-19. Be it protecting employees, customers or the overall business operations, we ensure that the employers take the right decisions, make strategic investments and maintain a healthy work culture along with taking probable measures to minimize the financial loss. Know More

According to Serbian law on health insurance, there is a defined list of patient who are eligible to receive rx/reimbursement services. There were no changes to the legislation framework which enables this service in 2019. The service includes the right to receive 60 units of incontinence products per month for: children aged 3-18 who have mental health problems causing incontinence; children aged 3-18 with neurogenically-induced incontinence; and patients with incontinence due to paraplegia, qu...

Euromonitor International's Rx/Reimbursement adult incontinence in Serbia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2015-2019, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market – be they new product developments, distribution or pricing issues. Forecasts to 2024 illustrate how the market is set to change.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Rx/Reimbursement adult incontinence market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
Rx/Reimbursement Adult Incontinence in Serbia
Euromonitor International
June 2020

List OF CONTENTS AND TABLES

HEADLINES
PRE-COVID-19 PERFORMANCE
Legislations to receive the reimbursement service remain the same
Pharmacies allowed to choose their own best suppliers
Removal of stigma could help more patients feel comfortable about service
2020 AND BEYOND
COVID-19 impact
Recovery and opportunities
CATEGORY DATA
Table 1 Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP 2014-2019
Table 2 Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP Growth 2014-2019
Table 3 Forecast Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP 2019-2024
Table 4 Forecast Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP Growth 2019-2024
EXECUTIVE SUMMARY
COVID-19 impact on tissue and hygiene
COVID-19 country impact
Partnership promotions between retail chains and brands boosted performance in 2019
Category leaders maintain their top places in 2019
No significant changes to projections, with opportunities based on both 2019 trends and 2020 needs
MARKET INDICATORS
Table 5 Birth Rates 2014-2019
Table 6 Infant Population 2014-2019
Table 7 Female Population by Age 2014-2019
Table 8 Total Population by Age 2014-2019
Table 9 Households 2014-2019
Table 10 Forecast Infant Population 2019-2024
Table 11 Forecast Female Population by Age 2019-2024
Table 12 Forecast Total Population by Age 2019-2024
Table 13 Forecast Households 2019-2024
MARKET DATA
Table 14 Retail Sales of Tissue and Hygiene by Category: Value 2014-2019
Table 15 Retail Sales of Tissue and Hygiene by Category: % Value Growth 2014-2019
Table 16 NBO Company Shares of Retail Tissue and Hygiene: % Value 2015-2019
Table 17 LBN Brand Shares of Retail Tissue and Hygiene: % Value 2016-2019
Table 18 Penetration of Private Label in Retail Tissue and Hygiene by Category: % Value 2014-2019
Table 19 Distribution of Retail Tissue and Hygiene by Format: % Value 2014-2019
Table 20 Distribution of Retail Tissue and Hygiene by Format and Category: % Value 2019
Table 21 Forecast Retail Sales of Tissue and Hygiene by Category: Value 2019-2024
Table 22 Forecast Retail Sales of Tissue and Hygiene by Category: % Value Growth 2019-2024
GLOBAL MACROECONOMIC ENVIRONMENT
GLOBAL INDUSTRY ENVIRONMENT
DISCLAIMER
SOURCES
Summary 1 Research Sources
Please enter your personal details below
*
I want to buy this report
I am willing to know the scope of research
I have customized query over this report
Please enter your personal details below
*
I want to buy this report
I am willing to know the scope of research
I have customized query over this report

Related Reports